Pfizer Seeks U.S. Clearance for Covid Boosters for Older Teens

Nov. 30, 2021, 10:39 PM

Pfizer Inc.’s chief executive said the company has asked the U.S. to allow Covid-19 booster shots for people age 16-17, a move that would expand access to additional doses amid worry about the new omicron virus variant.

Albert Bourla said in a tweet Tuesday that the company asked the Food and Drug Administration for emergency authorization of third doses for the age group. Shares of the drugmaker, which rose 2.5% in regular trading, gained 0.7% after hours in New York.

Currently, people age 5 and older in the U.S. are eligible to receive the messenger RNA vaccine, which Pfizer ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.